EssilorLuxottica Sees Share Recovery Possible as Medtech Shift and External Pressures Weigh on Stock
EssilorLuxottica's chief executive expressed confidence that the group's shares can recover the ground lost amid U.S. tariffs, a weak dollar, geopolitical tensions and intensifying competition in smart eyewear. Management says the company's strategic move into medtech is a deliberate, necessary transformation that will take time to deliver value bu…